Cargando…

Autoantibodies as Potential Biomarkers in Breast Cancer

Breast cancer is a major cause of mortality in women; however, technologies for early stage screening and diagnosis (e.g., mammography and other imaging technologies) are not optimal for the accurate detection of cancer. This creates demand for a more effective diagnostic means to replace or be comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Jingyi, Keyser, Bailey, Lin, Zuan-Tao, Wu, Tianfu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163859/ https://www.ncbi.nlm.nih.gov/pubmed/30011807 http://dx.doi.org/10.3390/bios8030067

Ejemplares similares

Autoantibodies as potential biomarkers for breast cancer
por: Zhong, Li, et al.
Publicado: (2008)

Autoantibodies as biomarkers for breast cancer diagnosis and prognosis
por: Yang, Ruozhu, et al.
Publicado: (2022)

Autoantibodies in Alzheimer’s disease: potential biomarkers, pathogenic roles, and therapeutic implications
por: Wu, Jianming, et al.
Publicado: (2016)

Autoantibody Biomarkers in Rheumatic Diseases
por: Kang, Eun Ha, et al.
Publicado: (2020)

Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021)

Use of Autoantibodies to Detect the Onset of Breast Cancer
por: Lacombe, Jérôme, et al.
Publicado: (2014)

Cardiac Biomarkers and Autoantibodies in Endurance Athletes: Potential Similarities with Arrhythmogenic Cardiomyopathy Pathogenic Mechanisms
por: Stadiotti, Ilaria, et al.
Publicado: (2021)

Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis
por: Graßhoff, Hanna, et al.
Publicado: (2022)

Autoantibodies as diagnostic biomarkers for lung cancer: A systematic review
por: Yang, Bin, et al.
Publicado: (2019)

MGMT autoantibodies as a potential prediction of recurrence and treatment response biomarker for glioma patients
por: Wu, Haibin, et al.
Publicado: (2019)

Biomarkers of the Metabolic Syndrome and Breast Cancer Prognosis
por: Zhu, Qiu-Li, et al.
Publicado: (2010)

Autoantibodies as Potential Biomarkers for the Early Detection of Esophageal Squamous Cell Carcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2014)

Tumor-associated autoantibodies as diagnostic and prognostic biomarkers
por: Heo, Chang-Kyu, et al.
Publicado: (2012)

Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases
por: Kocurova, Gabriela, et al.
Publicado: (2022)

Prevalence of serum galectin-1 autoantibodies in seven types of cancer: A potential biomarker
por: Nanami, Tatsuki, et al.
Publicado: (2021)

Protein Modifications as Potential Biomarkers in Breast Cancer
por: Jin, Hongjun, et al.
Publicado: (2009)

Circular RNAs as Potential Biomarkers in Breast Cancer
por: De Palma, Fatima Domenica Elisa, et al.
Publicado: (2022)

Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
por: Yoshifuji, Hajime
Publicado: (2016)

Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics
por: Conti, Valeria, et al.
Publicado: (2020)

Biomarkers of An Autoimmune Skin Disease—Psoriasis
por: Jiang, Shan, et al.
Publicado: (2015)

The Autoantibodies against Tumor-Associated Antigens as Potential Blood-Based Biomarkers in Thyroid Neoplasia: Rationales, Opportunities and Challenges
por: Belousov, Pavel V.
Publicado: (2022)

BMI-1 Autoantibody as a New Potential Biomarker for Cervical Carcinoma
por: Tong, Yong-Qing, et al.
Publicado: (2011)

Identification of the Thioredoxin-Like 2 Autoantibody as a Specific Biomarker for Triple-Negative Breast Cancer
por: Chung, Jee Min, et al.
Publicado: (2018)

Autoantibodies to Tumor-Associated Antigens in Breast Carcinoma
por: Piura, Ettie, et al.
Publicado: (2010)

Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC)
por: Dai, Liping, et al.
Publicado: (2013)

Relevance of Surface Neuronal Protein Autoantibodies as Biomarkers in Seizure-Associated Disorders
por: Stanciu, Gabriela Dumitrita, et al.
Publicado: (2019)

Screening of autoantibodies as biomarkers in the serum of renal cancer patients based on human proteome microarray: Screening of autoantibodies in renal cancer
por: Sun, Yangyang, et al.
Publicado: (2022)

Autoantibodies against p53, MMP-7, and Hsp70 as Potential Biomarkers for Detection of Nonmelanoma Skin Cancers
por: Yang, Shi-Han, et al.
Publicado: (2021)

Can serum autoantibodies be a potential early detection biomarker for breast cancer in women? A diagnostic test accuracy review and meta-analysis
por: Kathrikolly, Thejas, et al.
Publicado: (2022)

From rheumatic diseases to cancer - role of autoantibodies as diagnostic biomarkers
por: Tan, Eng M
Publicado: (2012)

Novel Prostate Cancer Biomarkers Derived from Autoantibody Signatures()
por: Schipper, Matthew, et al.
Publicado: (2015)

Autoantibodies associated with neuropsychiatric systemic lupus erythematosus: the quest for symptom-specific biomarkers
por: Sato, Shuzo, et al.
Publicado: (2020)

Significance of Autoantibodies to Ki/SL as Biomarkers for Systemic Lupus Erythematosus and Sicca Syndrome
por: Mahler, Michael, et al.
Publicado: (2022)

Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer
por: Li, Jitian, et al.
Publicado: (2016)

The Spectrum of Anti-Chromatin/Nucleosome Autoantibodies: Independent and Interdependent Biomarkers of Disease
por: Mehra, Sonal, et al.
Publicado: (2014)

miRNAs as potential biomarkers in early breast cancer detection following mammography
por: Fu, Sidney W., et al.
Publicado: (2016)

Autoantibodies in vasculitis
por: Wiik, Allan
Publicado: (2003)

Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy
por: Kazarian, Meleeneh, et al.
Publicado: (2011)

ER-α36: a novel biomarker and potential therapeutic target in breast cancer
por: Su, Xingyun, et al.
Publicado: (2014)

Serum Autoantibodies against LRDD, STC1, and FOXA1 as Biomarkers in the Detection of Ovarian Cancer
por: Duan, Yaru, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qbgingn8tsjq7pdoafummr9jta